Identification of Factors Affecting Tacrolimus Trough Levels in Latin American Pediatric Liver Transplant Patients-Reference-Cited by-同舟云学术

Identification of Factors Affecting Tacrolimus Trough Levels in Latin American Pediatric Liver Transplant Patients

Published:2019-06-25 Issue:9 Volume:25 Page:1397-1407
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Riva Natalia¹²^ORCID,Woillard Jean‐Baptiste³,Distefano Maximiliano⁴,Moragas Matias⁴,Dip Marcelo⁵,Halac Esteban⁵,Cáceres Guido Paulo¹,Licciardone Nieves⁶,Mangano Andrea⁴²,Bosaleh Andrea⁷,Davila María Teresa⁷,Schaiquevich Paula¹²,Imventarza Oscar⁵

Affiliation:

1. Unit of Clinical Pharmacokinetics Hospital de Pediatría Juan P. Garrahan Buenos Aires Argentina

2. Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) Buenos Aires Argentina

3. Department of Pharmacology and Toxicology University of Limoges, Centre Hospitalier Universitaire Limoges, INSERM, IPPRITT, U1248 Limoges France

4. Laboratory of Cell Biology and Retrovirus Hospital de Pediatría Juan P. Garrahan Buenos Aires Argentina

5. Liver Transplant Service Hospital de Pediatría Juan P. Garrahan Buenos Aires Argentina

6. Central Laboratory Hospital de Pediatría Juan P. Garrahan Buenos Aires Argentina

7. Pathology Service Hospital de Pediatría Juan P. Garrahan Buenos Aires Argentina

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lt.25495

Reference48 articles.

1. Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation

2. Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference

3. Increasing tacrolimus time‐in‐therapeutic range is associated with superior one‐year outcomes in lung transplant recipients

4. Pediatric liver transplantation: Personal perspectives on historical achievements and future challenges

5. Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevation of tacrolimus concentration after administration of methotrexate for treatment of graft-versus-host disease in pediatric patients received allogeneic hematopoietic stem cell transplantation;Journal of Pharmaceutical Health Care and Sciences;2023-12-05

2. Plasma metabolomic profiling reveals factors associated with dose-adjusted trough concentration of tacrolimus in liver transplant recipients;Frontiers in Pharmacology;2022-10-31

3. Strong influence of donor and recipient CYP3A5 genotype on tacrolimus disposition leading to difficult dose adjustment in a pediatric liver transplantation;Journal of Liver Transplantation;2022-10